These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
444 related articles for article (PubMed ID: 11556261)
1. [Treatment of germ cell tumors at the threshold of the third millennium]. Géczi L; Biron P; Droz JP Orv Hetil; 2001 Aug; 142(31):1673-9. PubMed ID: 11556261 [TBL] [Abstract][Full Text] [Related]
2. [Germ cell tumors of the testes: state of the art]. Fléchon A; Droz JP Cancer Radiother; 2000; 4(1):27-31. PubMed ID: 10742806 [TBL] [Abstract][Full Text] [Related]
3. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996]. Fléchon A; Biron P; Philip I; Blay JY; Droz JP Bull Cancer; 1999 Apr; 86(4):391-9. PubMed ID: 10341344 [TBL] [Abstract][Full Text] [Related]
4. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group. Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059 [TBL] [Abstract][Full Text] [Related]
12. Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors. Culine S; Theodore C; Farhat F; Bekradda M; Terrier-Lacombe MJ; Droz JP J Surg Oncol; 1996 Mar; 61(3):195-8. PubMed ID: 8637206 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of advanced testicular cancer and toxicity of chemotherapy]. Kawakita M; Matsuda T; Terachi T; Yoshida O Hinyokika Kiyo; 1999 Nov; 45(11):783-6. PubMed ID: 10637744 [TBL] [Abstract][Full Text] [Related]
14. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update]. Schmidt P; Haas RJ; Göbel U; Calaminus G Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897 [TBL] [Abstract][Full Text] [Related]
15. Surgery for testicular cancer: indication, results and technical aspects. Khouni H; Ghozzi S; Ramzi K; Smaali CH; Majed H; Ben Rais N Tunis Med; 2005 Dec; 83 Suppl 12():78-83. PubMed ID: 16430075 [TBL] [Abstract][Full Text] [Related]
16. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy. Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521 [TBL] [Abstract][Full Text] [Related]
18. The value of prognostic factors in the management of stage I nonseminomatous germ cell testicular tumors (NSGCTT). Ondrus D; Goncalves F; Kausitz J; Mat'oska J; Belan V Neoplasma; 1996; 43(3):195-7. PubMed ID: 8841507 [TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours. Fosså SD; Stenning SP; Gerl A; Horwich A; Clark PI; Wilkinson PM; Jones WG; Williams MV; Oliver RT; Newlands ES; Mead GM; Cullen MH; Kaye SB; Rustin GJ; Cook PA Br J Cancer; 1999 Jul; 80(9):1392-9. PubMed ID: 10424741 [TBL] [Abstract][Full Text] [Related]
20. [Retroperitoneal lymphadenectomy in disseminated non-seminoma germinogenic testicular tumors after chemotherapy in patients with elevated serum tumor markers]. Matveev VB; Volkova MI; Cherniev VA; Figurin KM; Mitin AV Urologiia; 2010; (3):41-7. PubMed ID: 20734877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]